ATE114315T1 - Radioaktive markierung von proteinen. - Google Patents

Radioaktive markierung von proteinen.

Info

Publication number
ATE114315T1
ATE114315T1 AT90905248T AT90905248T ATE114315T1 AT E114315 T1 ATE114315 T1 AT E114315T1 AT 90905248 T AT90905248 T AT 90905248T AT 90905248 T AT90905248 T AT 90905248T AT E114315 T1 ATE114315 T1 AT E114315T1
Authority
AT
Austria
Prior art keywords
labelled
thiotriphosphates
antibody
proteins
tumour
Prior art date
Application number
AT90905248T
Other languages
English (en)
Inventor
Brian Maurice John Foxwell
Peter Parker
Andrew Malcolm Creighton
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE114315T1 publication Critical patent/ATE114315T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Labeling Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90905248T 1989-03-23 1990-03-23 Radioaktive markierung von proteinen. ATE114315T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898906708A GB8906708D0 (en) 1989-03-23 1989-03-23 Improvements relating to the radiolabelling of proteins

Publications (1)

Publication Number Publication Date
ATE114315T1 true ATE114315T1 (de) 1994-12-15

Family

ID=10653894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905248T ATE114315T1 (de) 1989-03-23 1990-03-23 Radioaktive markierung von proteinen.

Country Status (8)

Country Link
EP (1) EP0464101B1 (de)
JP (1) JP2942776B2 (de)
AT (1) ATE114315T1 (de)
DE (1) DE69014300T2 (de)
DK (1) DK0464101T3 (de)
ES (1) ES2065525T3 (de)
GB (2) GB8906708D0 (de)
WO (1) WO1990011289A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583212A (en) * 1989-03-23 1996-12-10 British Technology Group Limited (gamma)-[32 p](gamma) -thioribonucleoside-51 -triphosphates
GB9103886D0 (en) * 1991-02-25 1991-04-10 Creighton Andrew 32p-thiophosphate preparation
GB9126650D0 (en) * 1991-12-16 1992-02-12 Creighton Andrew M Further improvements relating to the radiolabelling of proteins
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5728369A (en) * 1994-10-05 1998-03-17 Immunomedics, Inc. Radioactive phosphorus labeling of proteins for targeted radiotherapy
WO1996023816A1 (en) * 1995-02-01 1996-08-08 British Technology Group Limited Radiolabelled proteins
US6187286B1 (en) * 1996-12-27 2001-02-13 The General Hospital Corporation Tumor imaging agents, methods and kits

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
FR2585724B1 (fr) * 1985-08-01 1988-10-14 Centre Nat Rech Scient Kit de marquage enzymatique de nucleosides triphosphates et procede de preparation de nucleotides triphosphates marques au 32p ou 35s
GB2186579B (en) * 1986-01-21 1990-07-25 Brian Maurice John Foxwell Improvements relating to the radio-labelling of proteins

Also Published As

Publication number Publication date
EP0464101B1 (de) 1994-11-23
GB2248619A (en) 1992-04-15
DK0464101T3 (da) 1994-12-19
ES2065525T3 (es) 1995-02-16
JPH04503809A (ja) 1992-07-09
GB2248619B (en) 1993-02-24
DE69014300T2 (de) 1995-04-13
JP2942776B2 (ja) 1999-08-30
EP0464101A1 (de) 1992-01-08
GB8906708D0 (en) 1989-05-10
WO1990011289A1 (en) 1990-10-04
GB9119528D0 (en) 1991-12-04
DE69014300D1 (de) 1995-01-05

Similar Documents

Publication Publication Date Title
AU3066489A (en) Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
DK499086A (da) Konjugater af trichothecen og anvendelse af samme som terapeutisk substans
DE3575789D1 (de) Gleichseitige mehrfache proben und in denselben zu verwendende zusammensetzungen.
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
FI954347A0 (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
GB1257263A (de)
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
DE3372175D1 (en) Covalent conjugates of an enzyme and an antibody, and medicinal compositions containing these conjugates
DE68918867D1 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
AU3900589A (en) Antigenic constructs of major histocompatibility complex class 1 antigens with specific carrier molecules, the preparation and use thereof
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
GR3022089T3 (en) Synthetic antigens for the detection of antibodies to hepatitis C virus
DK543488A (da) Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne
Carter et al. Isolation and partial characterization of “galactoprotein a”(LETS) and “galactoprotein b” from hamster embryo fibroblasts
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
KR880000585A (ko) 임파선증 결합 바이러스에 대한 인체 모노클로날항체
ATE114315T1 (de) Radioaktive markierung von proteinen.
SE8103198L (sv) Forfarande for framstellning av antikroppar
DE3887750D1 (de) Selektive entfernung von immunkomplexen.
ATE88901T1 (de) Fluorkohlenstoffkette enthaltende antigene konjugate.
Parkhouse Non-covalent association of IgM subunits produced by reduction and alkylation
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
SE7904276L (sv) Renat cancerassocierat protein
SE8500340D0 (sv) Antikroppspreparation samt sett att framstella och sett att anvenda densamma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee